Sangamo Therapeutics
SGMO
SGMO
185 hedge funds and large institutions have $860M invested in Sangamo Therapeutics in 2019 Q2 according to their latest regulatory filings, with 33 funds opening new positions, 76 increasing their positions, 39 reducing their positions, and 31 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
6% more first-time investments, than exits
New positions opened: 33 | Existing positions closed: 31
1% less funds holding
Funds holding: 187 → 185 (-2)
Holders
185
Holding in Top 10
–
Calls
$26.2M
Puts
$15.7M
Top Buyers
| 1 | +$72.4M | |
| 2 | +$39.3M | |
| 3 | +$17.8M | |
| 4 |
BlackRock
New York
|
+$11.8M |
| 5 |
Nuveen Asset Management
Chicago,
Illinois
|
+$8.52M |
Top Sellers
| 1 | -$9.36M | |
| 2 | -$5.44M | |
| 3 | -$3M | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$2.1M |
| 5 |
D.E. Shaw & Co
New York
|
-$1.71M |